Skip to content

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06449573
Enrollment
15
Registered
2024-06-10
Start date
2024-03-01
Completion date
2025-03-31
Last updated
2024-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

Detailed description

It is thought that aerobic capacity of asthmatic individuals decreases due to chronic respiratory disease, especially oxygen consumption. Detailed investigation will be provided with this research.

Interventions

OTHERExercise capacity

cardiopulmonary exercise test used assessment of exercise capacity

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* No respiratory, cardiovascular and metabolic diseases * Regular non-smoker

Exclusion criteria

* Non-consenting * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Exercise capacity20 minutesExercise capacity will be assessed by Cardiopulmonary Exercise Test. The test will be performed on a bicycle ergometer. The test will be terminated when the target heart rate is reached or when the patient indicates that they are unable to continue the test. maximal oxygen consumption and the workload achieved will be recorded.

Secondary

MeasureTime frameDescription
Respiratory muscle strength8 minutesInspiratory and expiratory muscle strength will be measured with a mouth pressure measuring device. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright.
Peripheral muscle strength5 minutesIt will be evaluated with a portable manual muscle strength measuring device. Muscle strength of knee extensors will be measured. The measurement will be performed with the patient sitting with his/her back unsupported and his/her hands crossed on his/her chest.
Grip strength3 minutesIt will be evaluated with a portable hand dynamometer. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright. The measurement will be performed with the arm adjacent to the side of the trunk and the forearm parallel to the ground.
Kinesiophobia3 minutesTampa Kinesiophobia Scale will be used. A total of 17 questions will be answered in 4-point Likert form. In total, the patient scores between 17-68. A high score indicates high kinesiophobia.
Quality of Life (symptoms, mood, activity limitation, environmental exposure)10 minutesAsthma Quality of Life Scale will be used for the evaluation. This scale consists of 4 sub-headings including symptoms, mood, activity limitation, environmental exposure and 32 questions. Each item is scored between 1-7. The total score of the scale is calculated by averaging the scores given to the items. The higher the score, the better the quality of life.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAydan Aslı Aksel Uylar
aydanaaksel@gmail.com+90312

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026